Gierhart Wanda Marie sold (to issuer) $331K of CNK

Gierhart Wanda Marie (Chief Marketing & Content Ofc) sold (to issuer) 9,450 shares of Cinemark Holdings, Inc. (CNK) at $35.00 ($0.33M total) on 2026-07-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gierhart Wanda Marie
Published Jul 30, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 30, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNK
Neutral
high confidence
Mentioned
$CNK
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNKNeutralLow
01

Why it matters

The disclosed sale is pre-arranged under a Rule 10b5-1 plan, which generally limits the informational content for near-term valuation.

02

Market read

Traders may note the insider sale, but the 10b5-1 designation suggests it is not a fresh fundamental signal.

03

What to watch

The filing does not disclose any new business development, earnings, or risk event; traders should avoid over-weighting the sale without corroborating catalysts.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-30, transaction dated 2026-07-28

Background

The article is an SEC Form 4 insider transaction for Cinemark Holdings, Inc. (CNK) by its Chief Marketing & Content Officer.

Company-level read

Ticker impact

$CNKNeutralHigh confidence
Context

Cinemark officer Gierhart Wanda Marie sold 9,450 shares at $35.00 via a Rule 10b5-1 plan, reducing holdings to 58,082.

Expected impact

Low near-term impact; any reaction is likely muted unless paired with other company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction, but it explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No sector read-through; this is company-specific insider trading with no operational or guidance change disclosed.

None indicated.

None indicated.

Counterpoint

10b5-1 sales can coincide with routine liquidity needs and do not necessarily reflect bearish expectations.

Key entities

  • Cinemark Holdings, Inc.

    CNK, subject of the Form 4 insider sale disclosure.

  • Gierhart Wanda Marie

    Chief Marketing & Content Officer who sold 9,450 shares to the issuer at $35.00/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNKHigh

Morgan Stanley upgrades Cinemark stock rating on box office outlook

Morgan Stanley upgraded Cinemark (CNK) to Overweight with a $50 price target, citing optimism about 2027 box office growth and the company's strong market position. Cinemark's stock has risen 75.3% year-to-date, trading near its 52-week high. The company reported record Q3 earnings of $1.04 per share on $1.06 billion revenue, exceeding expectations. Other analysts have also raised their price targets following the strong performance.

$CNKHighAI 8/10

StoneX raises Cinemark stock price target on strong quarter

StoneX raised its price target on Cinemark (NYSE:CNK) to $45 from $40, citing strong Q3 results with revenue and adjusted EBITDA exceeding estimates. The firm expects continued growth in 2027, supported by a strong film slate and premium expansion. Cinemark's stock has surged 42% in six months. The company reported record Q3 earnings of $1.04 per share, beating estimates, with revenue reaching $1.06 billion.

$CNKMedAI 8/10

Cinemark stock holds at Neutral as B.Riley keeps $42 target

B.Riley maintained a Neutral rating and $42 price target for Cinemark (CNK) after its Q3 earnings beat estimates. Revenue was $1.059B, EBITDA $268M, driven by Latin America sales. Management is optimistic about future box office growth. Shares are up 65% YTD, trading near a 52-week high. Wells Fargo raised its target to $42, citing international success.

$CNKMed

Cinemark Holdings Inc (CNK) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue

Cinemark Holdings (CNK) reported record Q3 2026 revenue, but faced market share compression due to film mix and capacity constraints. The company expects similar challenges in Q4. Cinemark declined to book Netflix's 'Cliff Booth' on IMAX, citing concerns about the release model. Inflationary pressures and capacity constraints are impacting operations. The company has excess cash and may increase buybacks or dividends. CapEx could rise to invest in new builds and theater enhancements.